SZSE:301520 (China)
Â
Class A Shares
Â¥
40.60
(+1.2%)
Dec 24
Business Description
Anhui Wanbang Pharmaceutical Technology Co Ltd
ISIN : CNE1000068J8
Share Class Description:
SZSE:301520: Class A SharesCompare
Compare
Traded in other countries / regions
301520.China IPO Date
2023-09-25Description
Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.94 | |||||
| Interest Coverage | 3236.89 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 20.41 | |||||
| Beneish M-Score | -1.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 29.5 | |||||
| 3-Year EBITDA Growth Rate | 22.5 | |||||
| 3-Year EPS without NRI Growth Rate | 16.4 | |||||
| 3-Year Book Growth Rate | 93.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.9 | |||||
| 9-Day RSI | 33.52 | |||||
| 14-Day RSI | 39.39 | |||||
| 6-1 Month Momentum % | -6.73 | |||||
| 12-1 Month Momentum % | -23.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.4 | |||||
| Quick Ratio | 19.39 | |||||
| Cash Ratio | 15.88 | |||||
| Days Inventory | 1.56 | |||||
| Days Sales Outstanding | 51.73 | |||||
| Days Payable | 51.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.25 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| Forward Dividend Yield % | 1.25 | |||||
| 5-Year Yield-on-Cost % | 1.26 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1.18 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.17 | |||||
| Operating Margin % | 22.16 | |||||
| Net Margin % | 27.53 | |||||
| FCF Margin % | 0.07 | |||||
| ROE % | 7.35 | |||||
| ROA % | 6.96 | |||||
| ROIC % | 22.76 | |||||
| ROC (Joel Greenblatt) % | 55.91 | |||||
| ROCE % | 7.89 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.06 | |||||
| PE Ratio without NRI | 29.66 | |||||
| Price-to-Owner-Earnings | 32.68 | |||||
| PEG Ratio | 1.07 | |||||
| PS Ratio | 6.84 | |||||
| PB Ratio | 1.79 | |||||
| Price-to-Tangible-Book | 1.81 | |||||
| Price-to-Free-Cash-Flow | 20300 | |||||
| Price-to-Operating-Cash-Flow | 48.79 | |||||
| EV-to-EBIT | 12.89 | |||||
| EV-to-EBITDA | 12.89 | |||||
| EV-to-Revenue | 3.85 | |||||
| EV-to-FCF | 5884.29 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.9 | |||||
| Price-to-Graham-Number | 1.55 | |||||
| Price-to-Net-Current-Asset-Value | 2.08 | |||||
| Price-to-Net-Cash | 2.58 | |||||
| Earnings Yield (Greenblatt) % | 7.76 | |||||
| FCF Yield % | 0.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anhui Wanbang Pharmaceutical Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 394.457 | ||
| EPS (TTM) (Â¥) | 1.62 | ||
| Beta | 0 | ||
| Volatility % | 33.6 | ||
| 14-Day RSI | 39.39 | ||
| 14-Day ATR (Â¥) | 1.342375 | ||
| 20-Day SMA (Â¥) | 42.144 | ||
| 12-1 Month Momentum % | -23.34 | ||
| 52-Week Range (Â¥) | 33.88 - 60.48 | ||
| Shares Outstanding (Mil) | 66.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anhui Wanbang Pharmaceutical Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anhui Wanbang Pharmaceutical Technology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anhui Wanbang Pharmaceutical Technology Co Ltd Frequently Asked Questions
What is Anhui Wanbang Pharmaceutical Technology Co Ltd(SZSE:301520)'s stock price today?
The current price of SZSE:301520 is ¥40.60. The 52 week high of SZSE:301520 is ¥60.48 and 52 week low is ¥33.88.
When is next earnings date of Anhui Wanbang Pharmaceutical Technology Co Ltd(SZSE:301520)?
The next earnings date of Anhui Wanbang Pharmaceutical Technology Co Ltd(SZSE:301520) is .
Does Anhui Wanbang Pharmaceutical Technology Co Ltd(SZSE:301520) pay dividends? If so, how much?
The Dividend Yield %  of Anhui Wanbang Pharmaceutical Technology Co Ltd(SZSE:301520) is 1.25% (As of Today), Highest Dividend Payout Ratio of Anhui Wanbang Pharmaceutical Technology Co Ltd(SZSE:301520) was 0.37. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Anhui Wanbang Pharmaceutical Technology Co Ltd(SZSE:301520) is 1.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers